What type of drug is Steglatro?
Medically reviewed by Drugs.com. Last updated on Feb 26, 2020.
Steglatro (ertugliflozin) is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor.
This drug is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
The SGLT2 inhibitors block the kidney from reabsorbing sugar (glucose), which is then eliminated in the urine and lowers blood sugar.
Related Medical Questions
- Can you take Ibuprofen if you have COVID-19 (coronavirus)?
- Can vitamin C prevent or treat COVID-19 (coronavirus)?
- Basaglar and Lantus - What is the difference between them?
- How to avoid yeast infections on Jardiance?
- How many doses are in an Ozempic pen?
- How long does it take for Ozempic to work?
- Does Jardiance cause weight loss?
- Steglatro Information for Consumers
- Steglatro Information for Healthcare Professionals (includes dosage details)
- Side Effects of Steglatro (detailed)